Pfizer Ventures
Pfizer Ventures is the corporate venture capital arm of Pfizer, one of the world's largest pharmaceutical companies. They invest in innovative biotechnology and healthcare companies, with a focus on areas aligned with Pfizer's therapeutic interests and emerging modalities including the first pharma company to invest in a DAO.
Location
New York, New York, USA
Founded
2004
AUM
$600M+
Investment Range
$5M - $50M
Portfolio Companies
1
Focus
cvc
Fund Stages
seed, series-a, series-b, series-c
Investment Thesis
Pfizer Ventures invests in transformative healthcare companies at the forefront of science and technology. They focus on innovative therapeutic approaches, novel platforms, and healthcare technologies, providing strategic value through Pfizer's global R&D and commercial capabilities.
Team
Partners / Managing Directors (Health & Bio Focus)
- Barbara Dalton, PhD - Senior Vice President, Venture Investments
- Eddie Sullivan - Vice President, Venture Investments
Other Key Team Members
- Investment team with pharmaceutical R&D and commercial experience
Focus Areas
- Therapeutics (oncology, immunology, rare diseases)
- Gene therapy and cell therapy
- RNA therapeutics
- Drug discovery platforms
- Healthcare technology
- Longevity research (DeSci)
Notable Investments
- VitaDAO - $4.1M fundraising round (2023, first pharma company to invest in a DAO)
- Multiple early-stage biotech investments
- Focus on novel modalities and platforms
Notable Exits
- Strategic acquisitions aligned with Pfizer's interests
- Multiple IPOs in therapeutics
- Strong track record in oncology
Sources
- https://www.pfizer.com/science/innovation/pfizer-ventures
- https://www.pfizer.com/science/innovation/pfizer-ventures/team
- Pfizer annual reports
- PitchBook
Portfolio Companies
No companies found